0000950123-09-035195 Sample Contracts

SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • August 14th, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware

• Contract Type
  Securities Purchase Agreement
• Filed
  August 14th, 2009
• Company
  Alseres Pharmaceuticals Inc /De
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 12, 2009, by and among Alseres Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 239 South Street, Hopkinton, MA 01748 (the “Company”) and each investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors).

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDMENT NO. 1 TO LICENSE AGREEMENT

License Agreement • August 14th, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations • New York

• Contract Type
  License Agreement
• Filed
  August 14th, 2009
• Company
  Alseres Pharmaceuticals Inc /De
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDMENT (this “Amendment”) dated as of April 23, 2009 (“Amendment Effective Date”) is between Alseres Pharmaceuticals, Inc. (f/k/a Boston Life Sciences, Inc.), a Delaware corporation with offices at 85 Main Street, Hopkinton, MA 01748 (“Alseres”) and BioAxone Therapeutic Inc., a Canadian corporation with offices at 1100 Rene-Levesque West, 25th Floor, Montreal, QC H3B 5C9 Canada (“BA” and collectively with Alseres, the “Parties”).